anti-Bmf mAb (9G10)

AdipoGen Life Sciences
Product Code: AG-20T-0130
Product Group: Primary Antibodies
CodeSizePrice
AG-20T-0130-C100100 ug£300.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Antibody Clonality: Monoclonal
Regulatory Status: RUO
Target Species:
  • Human
  • Mouse
Applications:
  • Flow Cytometry
  • Immunoprecipitation (IP)
  • Western Blot (WB)
Shipping:
-20°C
Storage:
-20°C

Further Information

Alternate Names/Synonyms:
Bcl-2-modifying Factor
Concentration:
1mg/ml
EClass:
32160000
Endotoxin:
<0.1EU/µg purified protein (LAL test; Lonza).
Form (Short):
liquid
Formulation:
Liquid. In PBS containing 0.02% sodium azide.
Handling Advice:
Avoid freeze/thaw cycles.
Immunogen:
Recombinant mouse Bmf.
Long Description:
Monoclonal Antibody. Recognizes human and mouse Bmf. Detects several cross-reactivity bands of unknown identity in mice by western blot. Isotype: Rat IgG2akappa. Clone: 9G10. Applications: FACS, IP, WB. Liquid. In PBS containing 0.02% sodium azide. Bmf (Bcl-2-modifying factor) belongs to the Bcl-2 protein family. Bcl-2 family members form hetero- or homo-dimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. Bmf contains a single Bcl-2 homology domain 3 (BH3), and has been shown to interact with other Bcl-2 proteins and functions as an apoptotic activator. Two different start sites can give rise to two proteins of 25 or 30 kDa. It is found to be sequestered to myosin V motors by its association with dynein light chain 2 (DLC2), which may be important for sensing intracellular damage and triggering apoptosis.
NCBI, Uniprot Number:
Q96LC9
Package Type:
Plastic Vial
Product Description:
Bmf (Bcl-2-modifying factor) belongs to the Bcl-2 protein family. Bcl-2 family members form hetero- or homo-dimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. Bmf contains a single Bcl-2 homology domain 3 (BH3), and has been shown to interact with other Bcl-2 proteins and functions as an apoptotic activator. Two different start sites can give rise to two proteins of 25 or 30 kDa. It is found to be sequestered to myosin V motors by its association with dynein light chain 2 (DLC2), which may be important for sensing intracellular damage and triggering apoptosis.
Purity:
>95% (SDS-PAGE)
Specificity:
Recognizes human and mouse Bmf. Detects several cross-reactivity bands of unknown identity in mice by western blot.
Transportation:
Non-hazardous
UNSPSC Category:
Primary Antibodies
UNSPSC Number:
12352203
Use & Stability:
Stable for at least 1 year after receipt when stored at -20°C.

References

Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis: H. Puthalakath, et al.; Science 293, 1829 (2001) | Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells: M. Kochetkova, et al.; Cell Death Differ. 16, 664 (2009) | Suppression of B cell lymphomagenesis by the BH3-only proteins Bmf and Bad: A. Frenzel, et al.; Blood 115, 995 (2010) | BH3-only protein Bmf mediates apoptosis upon inhibition of CAP-dependent protein synthesis: F. Grespi, et al.; Cell Death Diff. 17, 1672 (2010) | Vorinostat-Induced Apoptosis in Mantle Cell Lymphoma Is Mediated by Acetylation of Proapoptotic BH3-Only Gene Promoters: S. Xargay-Torrent, et al.; Clin. Cancer Res. 17, 3956 (2011) | Haematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf: V. Labi, et al.; EMBO Mol. Med. 5, 122 (2013)